CJC-1295 (with DAC)
Long-acting GHRH analogue — one dose raises IGF-1 for over a week.
For research purposes only. These products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm these products will be used for legitimate research purposes.
About CJC-1295 (with DAC)
CJC-1295 is a synthetic analogue of growth hormone-releasing hormone (GHRH) carrying a Drug Affinity Complex (DAC) — a linker that binds covalently to serum albumin and extends the measured half-life to 5.8–8.1 days. In placebo-controlled dose-ranging studies in healthy adults, a single subcutaneous injection raised mean GH 2- to 10-fold for six days or more and IGF-1 1.5- to 3-fold for 9–11 days, and GH release stayed pulsatile rather than becoming continuous. Note that DAC is what defines this molecule: the product sold as "CJC-1295 no DAC" is tetrasubstituted GHRH(1-29), a different compound with a roughly 30-minute half-life and a completely different dosing schedule.
Key Benefits
- Sustained growth hormone elevation
- Supports deep restorative sleep
- Promotes lean muscle tissue repair
- Enhances collagen synthesis
Set a goal (top of the page) to see how CJC-1295 (with DAC) scores against it, and what the better-evidenced alternatives are.
Category Ratings
How to Take
Common Side Effects
- Flushing
- Headache
- Water retention
- Tingling or numbness
- Increased hunger
Legal & Regulatory Status
Research use only; not FDA-approved. Completed placebo-controlled dose-ranging studies in healthy adults and a Phase 2 study (HIV-associated visceral obesity); development was not carried forward. WADA-prohibited.
Safety and regulatory details for FDA-approved compounds are drawn from the official product label via openFDA; clinical development status reflects ClinicalTrials.gov. This information is provided for research reference, is not endorsed by the FDA, and may not be complete or current.
Research & Sources
- Prolonged stimulation of GH and IGF-I by CJC-1295 in healthy adults — primary dose-ranging trial, half-life 5.8-8.1 days (PMID 16352683)
- Pulsatile GH secretion persists during continuous stimulation by CJC-1295 (PMID 17018654)
Sources are selected for reliability (peer-reviewed literature, openFDA, ClinicalTrials.gov) but this is a research summary, not medical advice, and may not be exhaustive.
Prices at quality-checked sources · as of August 2026 (8 days ago)
- 5mg $34.79
- 2mg $41.455mg $58.13
- 5mg $86.99
Observed on each vendor’s public listing — see how these sources are vetted. Peptide Concierge doesn’t sell peptides and isn’t affiliated with any vendor; confirm current pricing at the source.
Builds a working set shared across the stack builder, calculator, scheduler and compare.